A Kia Corporation apresentou hoje seus novos modelos ... da nossa visão futura para redefinir o segmento, trazendo um novo nível de sofisticação e usabilidade para os motoristas.

Várias montadoras registraram quedas ao final da sessão, com a General Motors recuando 7,36%, a Stellantis perdendo mais de 1 ...

O Seu Dinheiro mostra para você como investir com inteligência, entregando notícias e análises sobre finanças, economia, ...

Na semana passada, foi noticiado que a AutoEuropa vai ser responsável pela construção de um novo carro elétrico e logo surgiu a dúvida: será que houve aproveitamento de Luís Montenegro ao ...

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

At the IIFA 2025 awards, Kartik Aaryan was honoured with the prestigious Best Actor (Male) award for his remarkable performance as Rooh Baba in ‘Bhool Bhulaiyaa 3′. His acceptance speech ...

Kia’s first electric sedan, the EV4, has officially hit the market. Kia opened EV4 orders at under $30,000 (41.92 million won) in South Korea ahead of its global rollout. It even has the longest ...

Leia também:"Peço desculpas de antemão": Kojima pede desculpas por personagem "ridículo" de Death Stranding 2: On the Beach Durante a revelação do novo trailer de Death Stranding 2: On The Beach, ...

After all, an update should also visibly change something for the user. Kia is promising exactly that with a major update and is also focusing on models that do not have the latest hardware installed.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest ...

Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema. Following the news, Morgan Stanley noted that the weight ...

Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop ...